The critical role of myostatin in differentiation of sheep myoblasts

Biochemical and Biophysical Research Communications
Chenxi LiuMingjun Liu

Abstract

Myostatin [MSTN, also known as growth differentiation factor 8 (GDF8)], is an inhibitor of skeletal muscle growth. Blockade of MSTN function has been reported to result in increased muscle mass in mice. However, its role in myoblast differentiation in farm animals has not been determined. In the present study, we sought to determine the role of MSTN in the differentiation of primary sheep myoblasts. We found that ectopic overexpression of MSTN resulted in lower fusion index in sheep myoblasts, which indicated the repression of myoblast differentiation. This phenotypic change was reversed by shRNA knockdown of the ectopically expressed MSTN in the cells. In contrast, shRNA knockdown of the endogenous MSTN resulted in induction of myogenic differentiation. Additional studies revealed that the induction of differentiation by knocking down the ectopically or endogenously expressed MSTN was accompanied by up-regulation of MyoD and myogenin, and down-regulation of Smad3. Our results demonstrate that MSTN plays critical role in myoblast differentiation in sheep, analogous to that in mice. This study also suggests that shRNA knockdown of MSTN could be a potentially promising approach to improve sheep muscle growth, so as to increase me...Continue Reading

References

Mar 1, 1993·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·J B MillerJ A Dominov
Jul 29, 1998·Mammalian Genome : Official Journal of the International Mammalian Genome Society·G SzabóL Varga
Sep 8, 2000·The Journal of Biological Chemistry·M ThomasR Kambadur
May 22, 2001·Cellular and Molecular Life Sciences : CMLS·M Kitzmann, A Fernandez
Feb 6, 2004·Nature Biotechnology·Angela ReynoldsAnastasia Khvorova
Jun 25, 2004·The New England Journal of Medicine·Elizabeth M McNally
Jul 12, 2005·Journal of Biotechnology·Jannel AcostaMario Pablo Estrada
Mar 29, 2006·Proceedings of the National Academy of Sciences of the United States of America·Michael C GoldingMark E Westhusin
Dec 14, 2006·ACS Chemical Biology·Ola Snøve, John J Rossi
Aug 12, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Raouia FakhfakhJacques P Tremblay
Sep 14, 2010·Trends in Biotechnology·Monica R LaresDominique L Ouellet

❮ Previous
Next ❯

Citations

Sep 21, 2013·In Vitro Cellular & Developmental Biology. Animal·Chenxi LiuMingjun Liu
Nov 19, 2015·Cellular Reprogramming·Huijun ShiChuangfu Chen
Apr 23, 2013·Biochemical and Biophysical Research Communications·Yongzhi TianMingjun Liu
Sep 23, 2014·PloS One·Bushuai ZhongFeng Wang
Sep 26, 2019·Frontiers in Genetics·Peter KaldsYulin Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

© 2021 Meta ULC. All rights reserved